Garo Armen and William O. Flannery were named directors.
They succeed inside directors Robert Fein, senior vice president of finance, and Robert Anacone, senior vice president of sales and marketing.
Mr. Armen, 41 years old, is general partner of Armen Partners L.P. and separately, Oracle Health Investors L.P., two investment management firms.
Mr. Flannery, 48, is the former general counsel for Thermo Electron Corp.
PerSeptive Technologies II is a research and development concern that develops products for human clinical diagnostic testing and therapeutic drug screening.
